Better Prostate Cancer Survival for Men Taki...( Study finds 10% improvement with chol...),Health

Study finds 10% improvement with cholesterol drugs

WEDNESDAY, Oct. 31 (HealthDay News) -- Men who were taking statins to lower their cholesterol had a 10 percent greater chance of being cured of prostate cancer by radiation therapy 10 years after diagnosis, a new study finds.

It's an "intriguing and very interesting finding," but falls short of supporting statin use for all prostate cancer patients, said study author Dr. Michael J. Zelefsky, a professor of radiation oncology at Memorial Sloan-Kettering Cancer Center in New York City. He was to deliver the results Wednesday at the American Society for Therapeutic Radiology and Oncology annual meeting, in Los Angeles.

"But I would encourage men to see their internist and get on the medications if their blood cholesterol warranted it," he said.

Zelefsky reported on 871 men given radiation therapy for prostate cancer between 1995 and 2000. The five-year relapse-free survival rate for the 168 men taking statins was 91 percent while the 10-year survival rate was 76 percent. That compares to 81 percent and 66 percent, respectively, for those not taking the drugs.

"There have been some reports of a lower risk of developing prostate cancer for those men who have been on statins," Zelefsky said, but the possible mechanisms by which the drugs might help prevent the disease or cure it are unknown.

"There was a suggestion made of a possible added benefit by an interaction between the drug and radiation," he said. "Or does it have its own independent effect? That is possible as well."

Zelefsky added that this study, and others suggesting a beneficial effect of statins on prostate cancer, "give fuel to stimulate what is the only way to absolutely corroborate such an effect, in a randomized, controlled trial."

Dr. Eric Horwitz, clinical director of radiation oncology at the Fox Chase Cancer Center in Philadelphia, said he agreed with Zelefsk
'/>"/>